ADAM17 and obesity disorder: Previous studies reported that the TIMP3/ADAM17 pathway is involved in the control of glucose homeostasis and inflammation in both genetic and nutritional models of obesity in mice, as well as in patients with obesity-related type 2 diabetes (T2D)7.